The precursor, a small ring-like protein fragment known as SFTI, has already shown potential as a cancer treatment. Until now, however, it has been considered too expensive to produce by conventional means.
Continue reading Could we grow drugs using sunflowers?
The trials—supervised by Prof Peter Timms and Prof Ken Beagley from Queensland University of Technology (QUT)’s Institute of Health and Biomedical Innovation—have been undertaken safely both in healthy koalas and koalas that already have chlamydial disease. All vaccinated koalas developed a good immune response to the anti-chlamydia vaccine, which shows great promise of making a significant impact on the disease in the near future.
Chlamydia is a major threat to the continued survival of koalas. Almost all populations in Australia are affected by the disease. It is a significant cause of infertility, urinary tract infections, and inflammation in the lining of the eye which often leads to blindness.
Koala numbers are declining across virtually its whole range. In the Koala Coast region of southeast Queensland in 2008 it was estimated that 2332 koalas had been lost in a three-year monitoring period. That represented a 51 per cent decrease.
By studying chlamydial disease in koalas, QUT researchers hope to understand the condition better in general. They believe their work may also hold the key to developing a successful vaccine for use against the human sexually transmitted disease Chlamydia trachomatis, a major cause of infertility in women.
Institute of Health and Biomedical Innovation, QUT, Peter Timms, Tel: +61 7 3138 6199, p.timms@qut.edu.au; www.ihbi.qut.edu.au/
Until now, correcting myopia has relied on measuring the clarity of vision at the very centre of the retina. Corrective lenses were designed to provide the wearer with clear central vision but did nothing for peripheral vision. Studies have now shown that short-sightedness progressively worsens in spite of correction using these traditional lenses.
The University of Melbourne’s Departments of Biochemistry and Molecular Biology, and Pharmacology have over recent years identified cone shell venom as a potential treatment for chronic pain in humans.
Researchers continue to develop the research into a commercialised product. One of the venom peptides identified is currently in phase two of clinical trials.
Want to throw away your reading glasses?
When we read or look at something close, the flexible lens inside our eye changes shape to provide the close focus required.
Most mothers are aware that breast milk helps boost their baby’s immune levels, but up to now it has been thought that it is mainly because of the mother’s antibodies found in human milk.
VESKI – Victorian Endowment for Science, Knowledge and Innovation – has awarded its latest Innovative Fellowships to two outstanding woman scientists.
VESKI was established with a $10 million endowment from the Victorian Government to entice talented expatriates home.
Continue reading Women at scientific forefront awarded new VESKI Innovation Fellowships
Most people recover from whiplash injuries within the first few months. However, some people have long term pain—lasting months or years. Until now there has been no way of diagnosing these more severe cases.
New research suggests that fat deposits in the neck muscles are the key.
“We’ve found that people with long term injury have large amounts of fat infiltration in their neck muscles,” says Dr James Elliott from the University of Queensland (and former US professional baseball player). “Something is causing that difference, and it isn’t their body weight,” he says.
A new oral vaccine against shellfish allergies is being developed by researchers at RMIT University.
Assoc. Prof. Andreas Lopata and his team in RMIT’s School of Applied Sciences are working to help find a different method for vaccination against the potentially deadly allergy.
What if the very thing that assists a fetus to grow in the womb could also prevent disease in a fully grown adult?
Monash Institute of Medical Research scientists have discovered that stem cells from the womb have the potential to treat inflammatory diseases such as lung fibrosis and liver cirrhosis in both children and adults.